KRAS and colorectal carcinoma: For example, the gain-of-function mutation in the oncogene Kirsten rat sarcoma viral oncogene homolog (KRAS) is one of the key mutations involving CRC progression and metastasis [24], and has been reported to be associated with poor patient survival [25].